The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  Re: NKTX Date:  7/10/2020  4:53 PM
Author:  Fuma102 Number:  25368 of 25442


I had actually just looked at their website and investor slide deck today.

Downside- SamsaraBio doesnt look like it brings alot of winners to market thusfar.

Lots of ifs here:
- *if* CAR-NK is cheaper & easier to manufacture
- *if* CAR-NK actually has lower CRS

*AND* if it's actually 34% or better response rate ( which is what their "overall" study response is- with trials ranging from 20% to 100% efficacy, with the largest trial of 42 patients showing 21%)

then we may have something. intriguing and something to keep an eye on, but I want to see some better data first. Still early.
Copyright 1996-2020 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us